444

OBI PHARMA INC

No trades
See on Supercharts
Market capitalization
‪13.82 B‬TWD
‪−1.05 B‬TWD
‪41.55 M‬TWD
‪196.17 M‬
Beta (1Y)
−0.05

About OBI PHARMA INC

CEO
Heidi Wang
Headquarters
Taipei
Founded
2002
ISIN
TW0004174008
FIGI
BBG003PBPW85
OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4174 is 60.8 TWD — it has increased by 0.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange OBI PHARMA INC stocks are traded under the ticker 4174.
OBI PHARMA INC is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4174 stock is 1.33% volatile and has beta coefficient of −0.05. Check out the list of the most volatile stocks — is OBI PHARMA INC there?
Yes, you can track OBI PHARMA INC financials in yearly and quarterly reports right on TradingView.
4174 stock has fallen by 4.40% compared to the previous week, the month change is a 3.49% fall, over the last year OBI PHARMA INC has showed a 31.14% decrease.
4174 net income for the last quarter is ‪−524.36 M‬ TWD, while the quarter before that showed ‪−567.84 M‬ TWD of net income which accounts for 7.66% change. Track more OBI PHARMA INC financial stats to get the full picture.
Today OBI PHARMA INC has the market capitalization of ‪13.82 B‬, it has decreased by 2.29% over the last week.
No, 4174 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4174 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OBI PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
4174 reached its all-time high on Dec 18, 2015 with the price of 740.8 TWD, and its all-time low was 58.0 TWD and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OBI PHARMA INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OBI PHARMA INC stock shows the sell signal. See more of OBI PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OBI PHARMA INC EBITDA is ‪−1.84 B‬ TWD, and current EBITDA margin is ‪−4.43 K‬%. See more stats in OBI PHARMA INC financial statements.